CAIX overexpression was observed in 56% (18/32) of BRCA1 mutation-related DCIS cases, with accompanying HIF-1α overexpression in 31% (10/32) of the cases (p = 0.358;Table 2). This evidence concerns the gene CA9 and ductal breast carcinoma in situ.